This site use cookies
This site uses cookies that help us to improve our site by providing analytics and usage information. By clicking accept or continuing to use this site you are agreeing to our cookie policy. If you do not agree, please close this notice. Learn more

Professor Pete Adamson

Head of Ophthalmology Research and Development at ProQR Therapeutics

Biography

Head of Ophthalmology Research and Development at ProQR Therapeutics an oligonucleotide company specialising in the treatment of rare inherited ophthalmic disease. Formerly Vice President and Head of Research at Ophthiris (GlaxoSmithKline Ophthalmology). Responsible for the scientific aspects of a number of high profile external alliances and the development of a number of internal assets which are currently undergoing clinical assessment. Pete has authored numerous peer-reviewed scientific publications in the domains of inflammation, ophthalmology and neurology. Pete retains an honorary appointment at UCL, Institute of Ophthalmology where he is Professor of Molecular Pathology.